BamSEC and AlphaSense Join Forces
Learn More

Aquestive Therapeutics Inc. – Indentures

NASDAQ: AQST    
Share price (9/28/26): $4.75    
Market cap (9/28/26): $596 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from S-3 15 pages Common Stock Purchase Warrant Aquestive Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Indenture or similar
12/34/56
EX-4.1
from S-8 22 pages Aquestive Therapeutics, Inc. 2022 Inducement Equity Incentive Plan Adopted by the Compensation Committee of the Board of Directors July 29, 2022 Aquestive Therapeutics, Inc. 2022 Inducement Equity Incentive Plan
12/34/56
EX-4.3
from S-3 36 pages Aquestive Therapeutics, Inc., as Issuer, and [Trustee], as Trustee, Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.1
from 8-K 172 pages Aquestive Therapeutics, Inc., as Issuer, and Any Guarantor That Becomes Party Hereto Pursuant to Section 4.10 Hereof 13.5% Senior Secured Notes Due 2028 Indenture Dated as of November 1, 2023 U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent
12/34/56
EX-4.1
from S-8 15 pages Aquestive Therapeutics, Inc. 2018 Equity Incentive Plan
12/34/56
EX-4.1
from 8-K 22 pages Indenture or similar
12/34/56
EX-4.2
from 8-K 18 pages Common Stock Purchase Warrant Aquestive Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Aquestive Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 5 pages Fifth Supplemental Indenture
12/34/56
EX-4.1
from 8-K 7 pages Indenture or similar
12/34/56
EX-4.1
from 8-K 7 pages Indenture or similar
12/34/56
EX-4.3
from S-3 36 pages Aquestive Therapeutics, Inc., as Issuer, and [Trustee], as Trustee, Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.4
from 10-K 11 pages Second Supplemental Indenture
12/34/56
EX-4.3
from 10-K 17 pages First Supplemental Indenture
12/34/56
EX-4.2
from S-3 24 pages Aquestive Therapeutics, Inc. Form of Common Stock Purchase Warrant
12/34/56
EX-4.2
from 8-K 7 pages Paycheck Protection Program Promissory Note
12/34/56
EX-4.7
from 10-K 3 pages Description of Securities
12/34/56
EX-4.3
from S-3 35 pages Aquestive Therapeutics, Inc., as Issuer, and [Trustee], as Trustee, Indenture Dated as of , 20 Debt Securities
12/34/56
EX-4.2
from 8-K 24 pages Aquestive Therapeutics, Inc. Common Stock Purchase Warrant
12/34/56